Wound gels serve crucial roles in wound management. Their applications encompass various wound types, including burns, ulcers, surgical wounds, and abrasions. These gels create a moist environment conducive to wound healing, facilitate debridement, and help control infection. Features of wound gel such as antimicrobial properties, pain relief, and ease of application enhance their effectiveness. Wound gels are invaluable in promoting tissue regeneration, reducing scarring, and providing a protective barrier, making them essential in modern wound care for improved patient comfort and faster recovery.
According to Data Bridge Market Research, the Global Wound Gel Market accounted for USD 20.00 billion in 2021 and is expected to reach USD 32.12 billion by 2029. The market is expected to grow with a CAGR of 6.10% in the forecast period of 2022 to 2029.
“Increasing prevalence of factors that negatively impact wound healing capabilities boosts the market’s growth”
The wound gel market is experiencing robust growth due to the increasing prevalence of factors that negatively impact wound healing capabilities. Factors such as chronic wounds, diabetes, and an aging population have led to a higher demand for wound care products, including wound gels. These gels offer a moist environment, promote tissue regeneration, and aid in infection control, accelerating the healing process. As these health issues become more prevalent, the wound gel market is expected to continue its growth trajectory in response to the rising need for effective wound management solutions.
What restraints the growth of the global wound gel market?
“High costs restraints the market’s growth”
The wound gel market encounters a significant impediment in the shape of elevated costs. While advanced wound gels prove highly effective, their development entails substantial expenses, including research, clinical trials, and regulatory adherence, which in turn can result in higher product prices for end-users. This financial barrier poses limitations, especially in healthcare systems with constrained budgets.
Segmentation: Global Wound Gel Market
The global wound gel market is segmented on the basis of type of wound type and end use.
- On the basis of wound type, the wound gel market is segmented into surgical wound, diabetic ulcers, pressure ulcers, venous ulcers, burns and others.
- On the basis of end use, the wound gel market is bifurcated into hospitals, clinics, ambulatory centers, home healthcare and others.
Regional Insights: North America dominates the Global Wound Gel Market
North America dominates the wound gel market as the region is witnessing an uptick in sports injuries and road accidents, driving demand for medical devices. The presence of key industry players, coupled with a skilled healthcare workforce and improved infrastructure, is catalyzing market growth. These factors collectively contribute to a flourishing medical device industry in the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing medical tourism industry. Patients from around the world seek high-quality healthcare services in these nations, boosting the demand for advanced medical devices and treatments, and consequently driving market expansion and development.
Recent Developments
- In Feburary 2020, Integra LifeSciences Holding Corporation, a prominent global medical technology firm, has introduced the AmnioExcel Plus Placental Allograft Membrane. This innovative wound care solution offers vital support for soft tissue repair. AmnioExcel Plus is an advanced tri-layer allograft, comprised of amnion, chorion, and amnion layers, designed to aid in the closure of challenging wounds. Utilizing DryFlex processing technology, it preserves the natural growth hormones, cytokines, and extracellular matrix (ECM) present in placental tissue, enhancing its therapeutic capabilities.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-wound-gel-market
The Prominent Key Players Operating in the Global Wound Gel Market Include:
- Smith+Nephew (U.K.)
- Mölnlycke Health Care AB (Sweden)
- Baxter (U.S.)
- 3M (U.S.)
- Integra LifeSciences (U.S.)
- ConvaTec Group Plc (U.K)
- Coloplast A/S (Denmark)
- Medtronic (Ireland)
- Johnson & Johnson Private Limited (U.S.)
- PAUL HARTMANN AG (Germany)
- MiMedx (U.S.)
- DeRoyal Industries Inc., (U.S.)
- Organogenesis Inc., (U.S.)
- Kerecis (Iceland)
- ACell Inc., (U.S.)
- Lohmann & Rauscher GmbH & Co. KG (Germany)
- Medela AG (Switzerland)
- Talley Group (England)
- Pensar Medical LLC (U.S.)
- B. Braun Melsungen AG (Germany)
- Cardinal Health (U.S.)
- Bioventus LLC. (U.S.)
- Zimmer Biomet (U.S.)
- DermaRite Industries LLC (U.S.)
- Medline Industries Inc., (U.S.)
- Brightwake Ltd (UK)
- MilLaboratories Pvt. Ltd. (India)
- Welcare Industries Spa. (Italy)
- Haromed BVBA (Belgium)
Above are the key players covered in the report, to know about more and exhaustive list of global wound gel market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Wound Gel Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
